Galapagos NV (GLPG)
32.57
+0.24
(+0.74%)
USD |
NASDAQ |
Dec 11, 16:00
32.59
+0.02
(+0.06%)
After-Hours: 20:00
Galapagos EPS Diluted (Quarterly): -3.584 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UCB SA | -- |
| Nyxoah SA | -0.7359 |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
| MDxHealth SA | -0.1618 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -238.38M |
| Revenue (Quarterly) | 83.16M |
| Total Expenses (Quarterly) | 321.53M |
| Enterprise Value | -1.429B |
| Gross Profit Margin (Quarterly) | 84.76% |
| Profit Margin (Quarterly) | -286.7% |
| Earnings Yield | -22.86% |
| Normalized Earnings Yield | -15.05 |